Liza‐Marie Johnson

1.5k total citations
75 papers, 799 citations indexed

About

Liza‐Marie Johnson is a scholar working on Pediatrics, Perinatology and Child Health, Public Health, Environmental and Occupational Health and Genetics. According to data from OpenAlex, Liza‐Marie Johnson has authored 75 papers receiving a total of 799 indexed citations (citations by other indexed papers that have themselves been cited), including 47 papers in Pediatrics, Perinatology and Child Health, 35 papers in Public Health, Environmental and Occupational Health and 12 papers in Genetics. Recurrent topics in Liza‐Marie Johnson's work include Childhood Cancer Survivors' Quality of Life (30 papers), Ethics and Legal Issues in Pediatric Healthcare (26 papers) and Palliative Care and End-of-Life Issues (23 papers). Liza‐Marie Johnson is often cited by papers focused on Childhood Cancer Survivors' Quality of Life (30 papers), Ethics and Legal Issues in Pediatric Healthcare (26 papers) and Palliative Care and End-of-Life Issues (23 papers). Liza‐Marie Johnson collaborates with scholars based in United States, Australia and Uganda. Liza‐Marie Johnson's co-authors include Justin N. Baker, Deena R. Levine, Belinda N. Mandrell, April Sykes, Zhaohua Lu, Jennifer M. Snaman, Erica C. Kaye, Doralina L. Anghelescu, Christopher L. Church and R. Ray Morrison and has published in prestigious journals such as Blood, PLoS ONE and PEDIATRICS.

In The Last Decade

Liza‐Marie Johnson

63 papers receiving 784 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Liza‐Marie Johnson United States 17 586 480 121 120 110 75 799
Eleanor Hendershot Canada 16 329 0.6× 176 0.4× 23 0.2× 31 0.3× 27 0.2× 28 609
Andrea S. Weintraub United States 16 139 0.2× 184 0.4× 31 0.3× 267 2.2× 66 0.6× 40 714
M. Braithwaite Australia 10 70 0.1× 243 0.5× 36 0.3× 57 0.5× 49 0.4× 17 416
Wendy Pelletier Canada 15 564 1.0× 309 0.6× 14 0.1× 70 0.6× 67 0.6× 36 749
Ruth Walker Australia 15 185 0.3× 272 0.6× 20 0.2× 173 1.4× 13 0.1× 50 798
Grace Meijuan Yang Singapore 16 172 0.3× 525 1.1× 9 0.1× 167 1.4× 80 0.7× 75 758
Yutaka Shirahige Japan 17 125 0.2× 564 1.2× 31 0.3× 240 2.0× 51 0.5× 40 836
Megan McCabe United States 12 95 0.2× 162 0.3× 11 0.1× 81 0.7× 51 0.5× 30 436
Kelly Irwin United States 12 177 0.3× 270 0.6× 20 0.2× 79 0.7× 10 0.1× 30 656
Meaghann S. Weaver United States 15 709 1.2× 706 1.5× 7 0.1× 115 1.0× 160 1.5× 46 1.0k

Countries citing papers authored by Liza‐Marie Johnson

Since Specialization
Citations

This map shows the geographic impact of Liza‐Marie Johnson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Liza‐Marie Johnson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Liza‐Marie Johnson more than expected).

Fields of papers citing papers by Liza‐Marie Johnson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Liza‐Marie Johnson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Liza‐Marie Johnson. The network helps show where Liza‐Marie Johnson may publish in the future.

Co-authorship network of co-authors of Liza‐Marie Johnson

This figure shows the co-authorship network connecting the top 25 collaborators of Liza‐Marie Johnson. A scholar is included among the top collaborators of Liza‐Marie Johnson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Liza‐Marie Johnson. Liza‐Marie Johnson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
3.
Cohen, A. S., Yoram Unguru, & Liza‐Marie Johnson. (2025). Yes, Parental Reasons Matter: Value-Laden Reactions Should Not Undermine the Utility of Knowing “Why”. The American Journal of Bioethics. 25(11). 44–46.
4.
Johnson, Liza‐Marie, Benjamin S. Wilfond, Andrew D. Ray, & Liza Dawson. (2025). Institutional Access to Gene Therapy for Sickle Cell Disease – Treatment on a Clinical Trial or Receive a Newly Approved Therapy?. The American Journal of Bioethics. 25(4). 145–146.
5.
Ray, Andrew D., Liza Dawson, Benjamin S. Wilfond, & Liza‐Marie Johnson. (2024). Disclosing Interim Results to Parents Offered Enrollment in a Fetal Intervention Trial. The American Journal of Bioethics. 24(10). 113–114. 1 indexed citations
6.
Johnson, Liza‐Marie, Akshay Sharma, Belinda N. Mandrell, et al.. (2024). Listening to patients and parents with sickle cell disease: the totality of gene therapy risks may outweigh the perceived benefits. Blood Advances. 8(21). 5723–5724. 2 indexed citations
7.
Persaud, Yogindra, Belinda N. Mandrell, Akshay Sharma, et al.. (2023). Attitudes toward COVID‐19 vaccine among pediatric patients with sickle cell disease and their caregivers. Pediatric Blood & Cancer. 70(5). e30274–e30274. 6 indexed citations
8.
Sharp, Katianne M. Howard, Chen Li, Zhaohua Lu, et al.. (2023). Parent Quality of Life After Disclosure of Pediatric Oncology Germline Sequencing Results. JCO Precision Oncology. 7(7). e2300159–e2300159. 6 indexed citations
9.
Johnson, Liza‐Marie, Belinda N. Mandrell, Chen Li, et al.. (2022). Managing Pandora’s Box: Familial Expectations around the Return of (Future) Germline Results. AJOB Empirical Bioethics. 13(3). 152–165. 9 indexed citations
10.
Johnson, Liza‐Marie. (2022). Time for a Reboot: Multimodal approaches to improving informed consent communication in pediatric oncology. Pediatric Blood & Cancer. 69(11). e29855–e29855. 1 indexed citations
11.
Mandrell, Belinda N., Liza‐Marie Johnson, Jami S. Gattuso, et al.. (2022). Parental Preferences Surrounding Timing and Content of Consent Conversations for Clinical Germline Genetic Testing Following a Child's New Cancer Diagnosis. JCO Precision Oncology. 6(6). e2200323–e2200323. 10 indexed citations
12.
Wilfond, Benjamin S., Devan M. Duenas, & Liza‐Marie Johnson. (2021). Supporting Community-Academic Research Partnerships: Reflections from the Ground. The American Journal of Bioethics. 21(10). 44–45. 1 indexed citations
13.
Johnson, Liza‐Marie, Devan M. Duenas, & Benjamin S. Wilfond. (2021). When Professional Meets Personal: How Should Research Staff Advertise on Social Media for Research Opportunities?. The American Journal of Bioethics. 21(10). 38–39. 1 indexed citations
14.
Wilfond, Benjamin S., Devan M. Duenas, & Liza‐Marie Johnson. (2020). Conflicts of Interest and Recommendations for Clinical Treatments That Benefit Researchers. The American Journal of Bioethics. 20(10). 90–91. 2 indexed citations
15.
Johnson, Liza‐Marie, Devan M. Duenas, & Benjamin S. Wilfond. (2020). Ethical Drug Development for Rare Childhood Diseases: When There Are Limited But Promising Data in Adults, How to Choose Between Safety or Efficacy Studies?. The American Journal of Bioethics. 20(4). 111–113. 1 indexed citations
16.
Wilfond, Benjamin S., Devan M. Duenas, & Liza‐Marie Johnson. (2020). Greater Than Minimal Risk, No Direct Benefit – Bridging Drug Trials and Novel Therapy in Pediatric Populations. The American Journal of Bioethics. 20(4). 102–103. 1 indexed citations
17.
Sisk, Bryan A., Kristin Canavera, Akshay Sharma, Justin N. Baker, & Liza‐Marie Johnson. (2019). Ethical issues in the care of adolescent and young adult oncology patients. Pediatric Blood & Cancer. 66(5). e27608–e27608. 26 indexed citations
18.
19.
Levine, Deena R., Erik Liederbach, Liza‐Marie Johnson, et al.. (2019). Are we meeting the informational needs of cancer patients and families? Perception of physician communication in pediatric oncology. Cancer. 125(9). 1518–1526. 30 indexed citations
20.
Johnson, Liza‐Marie, et al.. (1999). RATIONAL PRESCRIBING: PRACTICE AUDIT AND DRUG SWITCH IN DYSPEPSIA MANAGEMENT. International Journal of Clinical Practice. 53(8). 599–603. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Eleanor Hendershot Breakdown of academic impact, for papers by Andrea S. Weintraub Breakdown of academic impact, for papers by M. Braithwaite Breakdown of academic impact, for papers by Wendy Pelletier Breakdown of academic impact, for papers by Ruth Walker Breakdown of academic impact, for papers by Grace Meijuan Yang Breakdown of academic impact, for papers by Yutaka Shirahige Breakdown of academic impact, for papers by Megan McCabe Breakdown of academic impact, for papers by Kelly Irwin Breakdown of academic impact, for papers by Meaghann S. Weaver
Rankless by CCL
2026